<?xml-stylesheet type='text/xsl' href='anzctrTransform.xsl'?>
<ANZCTR_Trial requestNumber="363040">
  <stage>Registered</stage>
  <submitdate>17/09/2012</submitdate>
  <approvaldate>18/09/2012</approvaldate>
  <actrnumber>ACTRN12612001004853</actrnumber>
  <trial_identification>
    <studytitle>Effects of common sleeping pills on arousal and muscle function during sleep</studytitle>
    <scientifictitle>Effects of common sedatives on respiratory arousal and upper airway muscle function during sleep in healthy men and women with and without sleep apnoea</scientifictitle>
    <utrn>Nil</utrn>
    <trialacronym>Nil</trialacronym>
    <secondaryid>Nil</secondaryid>
  </trial_identification>
  <conditions>
    <healthcondition>Sleep apnoea</healthcondition>
    <conditioncode>
      <conditioncode1>Respiratory</conditioncode1>
      <conditioncode2>Sleep apnoea</conditioncode2>
    </conditioncode>
  </conditions>
  <interventions>
    <interventions>Arm 1: temazepam (10mg), once only immediately before going to bed, taken orally
Arm 2 zopiclone (7.5mg), once only immediately before going to bed, taken orally
Arm 3: zolpidem (10mg), once only immediately before going to bed, taken orally
1 week washout between treatments</interventions>
    <comparator>Placebo, taken orally (participants will act as thier own controls in a cross-over design)</comparator>
    <control>Placebo</control>
    <interventioncode>Treatment: drugs</interventioncode>
  </interventions>
  <outcomes>
    <primaryOutcome>
      <outcome>Respiratory arousal threshold (negative pharyngeal pressure immediately prior to arousal from sleep using an epiglottic pressure catheter inserted via the nostril)</outcome>
      <timepoint>Acute overnight studies on drug vs. placebo</timepoint>
    </primaryOutcome>
    <secondaryOutcome>
      <outcome>Upper airway muscle responsiveness (EMG)</outcome>
      <timepoint>Acute overnight studies on drug vs. placebo</timepoint>
    </secondaryOutcome>
    <secondaryOutcome>
      <outcome>Upper airway collapsibility (Pcrit)</outcome>
      <timepoint>Acute overnight studies on drug vs. placebo</timepoint>
    </secondaryOutcome>
    <secondaryOutcome>
      <outcome>Respiratory control stability (loop gain)</outcome>
      <timepoint>Acute overnight studies on drug vs. placebo</timepoint>
    </secondaryOutcome>
    <secondaryOutcome>
      <outcome>Ventilatory responses</outcome>
      <timepoint>Acute overnight studies on drug vs. placebo</timepoint>
    </secondaryOutcome>
  </outcomes>
  <eligibility>
    <inclusivecriteria>Healthy men and women with and without sleep apnoea</inclusivecriteria>
    <inclusiveminage>18</inclusiveminage>
    <inclusiveminagetype>Years</inclusiveminagetype>
    <inclusivemaxage>65</inclusivemaxage>
    <inclusivemaxagetype>Years</inclusivemaxagetype>
    <inclusivegender>Both males and females</inclusivegender>
    <healthyvolunteer>Yes</healthyvolunteer>
    <exclusivecriteria>-Known allergy or previous adverse reaction to temazepam, zopiclone or zolpidem
-Medications known to affect muscle activity or sleep
-Pregnant or nursing mothers</exclusivecriteria>
  </eligibility>
  <trial_design>
    <studytype>Interventional</studytype>
    <purpose>Treatment</purpose>
    <allocation>Randomised controlled trial</allocation>
    <concealment />
    <sequence />
    <masking>Blinded (masking used)</masking>
    <assignment>Crossover</assignment>
    <designfeatures />
    <endpoint>Efficacy</endpoint>
    <statisticalmethods />
    <masking1 />
    <masking2 />
    <masking3 />
    <masking4 />
    <patientregistry />
    <followup />
    <followuptype />
    <purposeobs />
    <duration />
    <selection />
    <timing />
  </trial_design>
  <recruitment>
    <phase />
    <anticipatedstartdate>25/09/2012</anticipatedstartdate>
    <actualstartdate>27/09/2012</actualstartdate>
    <anticipatedenddate />
    <actualenddate>26/08/2015</actualenddate>
    <samplesize>25</samplesize>
    <actualsamplesize>28</actualsamplesize>
    <recruitmentstatus>Completed</recruitmentstatus>
    <anticipatedlastvisitdate />
    <actuallastvisitdate>8/10/2015</actuallastvisitdate>
    <dataanalysis />
    <withdrawnreason />
    <withdrawnreasonother />
    <recruitmentcountry>Australia</recruitmentcountry>
    <recruitmentstate>NSW</recruitmentstate>
  </recruitment>
  <sponsorship>
    <primarysponsortype>Other</primarysponsortype>
    <primarysponsorname>Neuroscience Research Australia</primarysponsorname>
    <primarysponsoraddress>Barker Street
Randwick
NSW 2031</primarysponsoraddress>
    <primarysponsorcountry>Australia</primarysponsorcountry>
    <fundingsource>
      <fundingtype>University</fundingtype>
      <fundingname>University of New South Wales</fundingname>
      <fundingaddress>UNSW Medicine
University of New South Wales
SYDNEY NSW 2052</fundingaddress>
      <fundingcountry>Australia</fundingcountry>
    </fundingsource>
    <fundingsource>
      <fundingtype>Government body</fundingtype>
      <fundingname>NHMRC (APP1042493)</fundingname>
      <fundingaddress>National Health and Medical Research Council
GPO Box 1421
Canberra ACT 2601</fundingaddress>
      <fundingcountry>Australia</fundingcountry>
    </fundingsource>
    <secondarysponsor>
      <sponsortype>None</sponsortype>
      <sponsorname />
      <sponsoraddress />
      <sponsorcountry />
    </secondarysponsor>
  </sponsorship>
  <ethicsAndSummary>
    <summary>The purpose of this physiology study is to examine the effects of common sleeping pills (sedatives) on the awakening (arousal) response to respiratory stimuli during sleep and their effects on upper airway muscles, airway function, and breathing responses during sleep.</summary>
    <trialwebsite>Nil</trialwebsite>
    <publication>Carberry JC, Fisher LP, Grunstein RR, Gandevia SC, McKenzie DK, Butler JE, Eckert DJ. Effects of Hypnotics on the Phenotypic Causes of Obstructive Sleep Apnea. Am J Respir Crit Care Med 2017; 195: A7531 [abstract to be presented at ATS, May 2017].</publication>
    <ethicsreview>Approved</ethicsreview>
    <publicnotes>Nil</publicnotes>
    <ethicscommitee>
      <ethicname>University of New South Wales Human Research Ethics Committee</ethicname>
      <ethicaddress>UNSW Grants Management Office
Rupert Myers Building, Level 3, South Wing
The University of New South Wales 
SYDNEY NSW 2052</ethicaddress>
      <ethicapprovaldate>14/03/2012</ethicapprovaldate>
      <hrec>HC12028</hrec>
      <ethicsubmitdate />
      <ethiccountry>Australia</ethiccountry>
    </ethicscommitee>
  </ethicsAndSummary>
  <attachment />
  <contacts>
    <contact>
      <title>Dr</title>
      <name>Dr. Danny Eckert</name>
      <address>Neuroscience Research Australia
Barker Street
Randwick, NSW
2031</address>
      <phone>+61 2 9399 1814</phone>
      <fax />
      <email>d.eckert@neura.edu.au</email>
      <country>Australia</country>
      <type>Scientific Queries</type>
    </contact>
    <contact>
      <title>Dr</title>
      <name>Dr. Danny Eckert</name>
      <address>Neuroscience Research Australia
Barker Street
Randwick, NSW
2031</address>
      <phone>+61 2 9399 1814</phone>
      <fax />
      <email>d.eckert@neura.edu.au</email>
      <country>Australia</country>
      <type>Public Queries</type>
    </contact>
    <contact>
      <title />
      <name>Dr. Danny Eckert</name>
      <address>Neuroscience Research Australia
Barker Street
Randwick, NSW
2031</address>
      <phone>+61 2 9399 1814</phone>
      <fax />
      <email>d.eckert@neura.edu.au</email>
      <country>Australia</country>
      <type>Updating Information</type>
    </contact>
    <contact>
      <title>Dr</title>
      <name>Danny Eckert</name>
      <address>Neuroscience Research Australia Barker Street Randwick, NSW 2031</address>
      <phone>+61 2 9399 1814</phone>
      <fax />
      <email>d.eckert@neura.edu.au</email>
      <country>Australia</country>
      <type>Principal Investigator</type>
    </contact>
  </contacts>
</ANZCTR_Trial>